Parathyroid Hormone and Pain

  • Carlo Gennari

Abstract

In recent years, it has been suggested that calcitonin (CT), in addition to well known action on calcium and phosphate metabolism, may also exert effects as a neuromodulator. In fact, evidence has been given that CT potentiates haloperidol-induced catalepsy in rats (1), decreases glutammic acid decarboxylase (GAD) activity in the substantia nigra (2), decreases plasma prolactin level in rats and in healthy subjects (3,4), induces analgesia in animals and man (5,6), and inhibits gastric acid secretion and feeding in rats (7,8).

Keywords

Adenoma Morphine Serotonin Norepinephrine Acetylcholine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G. Clementi, A. Prato, R. Bernardini, F. Nicoletti, F. Patti, D. De Simone, and U. Scapagnini, Effects of calcitonin on the brain of aged rats, Neurobiol. Aging 4:229–232 (1983)PubMedCrossRefGoogle Scholar
  2. 2.
    F. Nicoletti, G. Clementi, F. Patti, P.L. Canonico, R.M. Di Giorgio, M. Matera, G. Pennisi, L. Angelucci, U. Scapagnini, Effects of calcitonin on rat extrapyramidal motor system: behavioral and biochemical data, Brain Res.250:381–385 (1982).PubMedCrossRefGoogle Scholar
  3. 3.
    G. Clementi, F. Nicoletti, F. Patacchioli, A. Prato, F. Patti, M. Matera, and U. Scapagnini, Hypoprolactinemic action of calcitonin and the tuberoinfundi bular dopaminergic system, J. Neurochem. 40:885–886 (1983)PubMedCrossRefGoogle Scholar
  4. 4.
    R. Isaac, R. Merceron, G. Coillens, J.P. Raymond, and R. Ardaillou, Effects of calcitonin on basal and thyrotropin releasing hormone stimulated prolactin secretion in man, J. Clin. Endocrinol. Metab. 50:1011–1015 (1980).PubMedCrossRefGoogle Scholar
  5. 5.
    A. Pecile, S. Ferri, P.C. Braga, V.R. Olgiati, Effects of intrace-rebroventricular calcitonin in the conscious rabbit, Experientia31: 332–333 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    C. Gennari, Clinical aspects of calcitonin in pain, Triangle22: 157–163 (1983).Google Scholar
  7. 7.
    J. E. Morley, A. S. Levine, S. E. Silvis, Intraventricular calcitonin inhibits gastric acid secretion, Science214: 671–673 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    W. J. Freed, M. J. Perlow, R. J. Wyatt, Calcitonin: inhibitory effect on eating in rats, Science206: 850–852 (1979).PubMedCrossRefGoogle Scholar
  9. 9.
    F. Nicoletti, G. Clementi, F. Patti, A. Prato, R. M. Di Giorgio, and U. Scapagnini, Effects of parathyroid hormone one haloperidol induced catalepsy and nigral GAD activity, Eur. J. Pharmacol. 88:135–136 (1983).PubMedCrossRefGoogle Scholar
  10. 10.
    G. Clementi, F. Drago, M. Amico-Rowas, A. Prato, E. Rapisarda, F. Nicoletti, G. Rodolico, U. Scapagnini, Central actions of calcitonin and parathyroid hormone, in: “Calcitonin 1984: Chemistry, Physiology, Pharmacology, and Clinical Aspects”, A. Pecile ed., Excerpta Medica, Amsterdam, pp. 279–286 (1985).Google Scholar
  11. 11.
    G. Clementi, M. Amico-Roxas, F. Nicoletti, E.C. Fiore, A. Prato, U. Scapagnini, Hyperalgesic activity of parathyroid hormone and its fragments in male rats, Brain Res.295: 376–377 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    J. A. Fischer, S. M. Sagar, J. B. Martin, Characterization and regional distribution of calcitonin binding sites in the rat brain, Life Sci.29: 663–671 (1981).PubMedCrossRefGoogle Scholar
  13. 13.
    F. A. Tschopp, H. Henke, J. B. Peterman, P. H. Tobler, R. Janzer, T. Hökfelt, J. M. Lundberg, C. Cuello and J. A. Fischer, Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary, Proc. Natl. Acad. Sci. USA 82:248–252 (1985).PubMedCrossRefGoogle Scholar
  14. 14.
    M. G. Rosenfeld, S. G. Amara, R. M. Evans, Alternative RNA processing: determining neuronal phenotype, Science225: 1315–1320 (1984).PubMedCrossRefGoogle Scholar
  15. 15.
    J. A. Fischer, P. H. Tobler, M. Kaufmann, W. Born, H. Henke, P.E. Cooper, S. M. Sagar, and J. B. Martin, Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary, Proc. Natl. Acad. Sci. USA 78:7801–7805 (1981)PubMedCrossRefGoogle Scholar
  16. 16.
    D. M. Pavlinac, L. W. Lenhard, J. G. Parthemore, and L. J. Deftos, Immunoreactive calcitonin in human cerebrospinal fluid, J. Clin. Endocrinol. 50:717–720 (1980).CrossRefGoogle Scholar
  17. 17.
    F. Loffler, D. Van Calker, B. Hamprecht, parathyrin and calcitonin stimulate cyclic AMP accumulation in cultured murine brain cells, The EMBO J.1: 297–302 (1982).Google Scholar
  18. 18.
    G. R. Mundy, T. J. Martin, The hypercalcemia of malignancy: pathogenesis and management, Metabolism31: 1247–1277 (1983).Google Scholar
  19. 19.
    F. Guerrero-Muñoz, M. De Lourdes Guerrero, E. Leong Way, C. Haoli, Effect of B-endorphin on calcium uptake in the brain, Science206: 89–91 (1979).Google Scholar
  20. 20.
    A. I. Arieff, and S. G. Massry, Calcium metabolism of brain in acute renal failure, J. Clin. Invest. 53:387–392 (1974).PubMedCrossRefGoogle Scholar
  21. 21.
    D. A. Goldstein, M. Romoff, E. Bogin, and S. G. Massry, Relationship between the concentrations of calcium and phosphorus in blood and cerebrospinal fluid, J. Clin. Endocrinol. Metab. 49:58–62 (1979).PubMedCrossRefGoogle Scholar
  22. 22.
    M. Akmal, D. A. Goldstein, S. A. Tuma, P. Fanti, R. Pattabhiraman, and S. G. Massry, The effect of parathoid hormone (PTH) on the blood-brain barrier, Clin. Res. 31:52A (1983).Google Scholar
  23. 23.
    A. D. Care, N. H. Bell, Evidence that parathyroid hormone crosses the blood brain barrier, in: “IXth International Conference on Calcium Regulating Hormones and Bone Metabolism”, Nice oct. 25–nov. 1, 1986, Volume of Abstracts, Abstract 122, p. 181 (1986).Google Scholar
  24. 24.
    D. A. Goldstein, E. I. Feinstein, L. A. Chui, R. Pattabhiraman, and S. G. Massry, The relationship between the abnormalities in electroencephalogram and blood levels of PTH in dyalisis patients, J. Clin. Endocrinol. Metab. 51:130–134 (1980).PubMedCrossRefGoogle Scholar
  25. 25.
    E. M. Allen, F. R. Singer, D. Melamed, Electroencephalographic abnormalities in hypercalcemia, Neurology20: 15–23, 1970.PubMedGoogle Scholar
  26. 26.
    R. Guisado, A. I. Arieff, and S. G. Massry, Changes in the electronic cephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes, J. Clin. Invest. 55:738–745 (1975).PubMedCrossRefGoogle Scholar
  27. 27.
    S. G. Massry, Neurotoxicity of parathyroid hormone in uremia. Kidney Int.28 (suppl. 17): S5–S11 (1985).Google Scholar
  28. 28.
    M. G. Cogan, C. M. Covey, A. I. Arieff, A. Wisniesky, O. H. Clark, V. Lazarowitz, and W. Leach, Central nervous system manifestations of hyperparathyroidism, Am. J. Med. 65:963–971 (1978).PubMedCrossRefGoogle Scholar
  29. 29.
    J. W. Gatewood, C. H. Organ, and B. T. Mead, Mental changes associated with hyperparathyroidism, Am. J. Psychiatry 132:129–132 (1975).PubMedGoogle Scholar
  30. 30.
    J. L. Crammer, Calcium metabolism and mental disorder, Psychol. Med. 7:557–560 (1977).PubMedCrossRefGoogle Scholar
  31. 31.
    M. E. Gibbs, C. L. Gibbs, and K. T. Ng, A possible physiological mechanism for short-term memory, Physiol. Behav. 20:619–627 (1978).PubMedCrossRefGoogle Scholar
  32. 32.
    M. E. Gibbs, C. L. Gibbs, and K. T. Ng, The influence of calcium on short-term memory, Neurosci. Lett. 14:255–360 (1979).CrossRefGoogle Scholar
  33. 33.
    G. Clementi, F. Drago, A. Prato, S. Cavaliere, A. Di Benedetto, F. Leone, U. Scapagnini, and G. Rodolico, Effects of calcitonin, parathyroid hormone and its related fragments on acquisition of active avoidance behavior, Physiol. Behav. 33:913–916 (1984).PubMedCrossRefGoogle Scholar
  34. 34.
    A. B. Borle, Calcium metabolism at the cellular level, Fed. Proc. 30:1944–1950 (1973).Google Scholar
  35. 35.
    D. A. Goldstein, L. A. Chui, and S. G. Massry, Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity, J. Clin. Invest. 62:88–93 (1978).PubMedCrossRefGoogle Scholar
  36. 36.
    J. A. Parsons, R. M. Neer, J. T. Potts Jr., Initial fall of plasma calcium after intravenous injection of parathyroid hormone, Endocrinology89: 735–740 (1971).Google Scholar
  37. 37.
    W. G. Robertson, M. Peacock, D. Atkins, and L. A. Webster, The effect of parathyroid hormone on the uptake and release of calcium by bone in tissue culture, Clin. Sci. 43:715–718 (1972).Google Scholar
  38. 38.
    A. Caniggia, C. Gennari, Early effects of calcitonin in man: comparison with the early effects of parathyroid hormone, in: “Calcium Regulating Hormones”, R. V. Talmage, M. Owen, J. A. Parsons, Excerpta Medica, Amsterdam, pp. 154–156 (1975).Google Scholar
  39. 39.
    A. Caniggia, C. Gennari, F. Piantelli, and A. Vattimo, Initial increase of plasma radioactive calcium after intravenous injection of calcitonin in man, Clin. Sci. 43:171–180 (1972).PubMedGoogle Scholar
  40. 40.
    E. Bogin, S. G. Massry, J. Levi, M. Djaldeti, G. Bristol, and J. Smith, Effect of parathyroid hormone on osmotic fragility of human erythrocytes, J. Clin. Invest. 69:1017–1025 (1982).PubMedCrossRefGoogle Scholar
  41. 41.
    C. Gennari, M. Montagnani, R. Civitelli, D. Agnusdei, R. Nami, and S. Bigazzi, Calcitonina, ormone paratiroideo, ione calcio, 3,5-adeno-sinmonofosfato ciclico (AMPc) e deformabilitä eritrocitaria, La Ricerca Clin. Lab. 15(suppl. l):465–473 (1985).Google Scholar
  42. 42.
    D. K. Parkinson, I. C. Radde, Calcitonin action on membrane ATPase - a hypothesis, in: “Calcitonin 1969. Proceedings of the Second International Symposium”, Heinemann Medical Books, London, pp. 466–471 (1970).Google Scholar
  43. 43.
    C. Gennari, M. Montagnani, R. Nami, R. Civitelli, P. Bartalini, C. Bianchini, E. Maioli, The effects of calcitonins on erythrocyte filtration and calmodulin content in man, in: “VIII International Conference on Calcium Regulating Hormones”, Kobe, Japan October 16–24, 1983, abstracts book p. 33 (1983).Google Scholar
  44. 44.
    H. Lo, D. C. Lehotay, D. Katz, and G. S. Levey, Parathyroid hormone-mediated incorporation of 32P orthophosphate into phosphatidic acid and phosphatidylinositol in renal cortical slices, Endocr. Res. Commun. 3:377–385 (1976).PubMedCrossRefGoogle Scholar
  45. 45.
    K. A. Hruska, D. Moskowitz, P. Esbrit, R. Civitelli, S. Westbrook, and M. Huskey, Stimulation of inositol triphosphate and diacylglycerol production in renal tubular cells by parathyroid hormone, J. Clin. Invest. 79:230–239 (1987).PubMedCrossRefGoogle Scholar
  46. 46.
    G. Clementi, U. Scapagnini, Personal communication, (1987).Google Scholar
  47. 47.
    J. J. Rohner, D. Planche, and F. Boudouresque, Calcitonin induced analgesia: experimental study suggesting both a morphine-like and a cortisone-like effect, Calcif. Tissue Int. 36(suppl.):S78 (1984).Google Scholar
  48. 48.
    C. Gennari, Calcitonin and bone metastases of cancer, in: “Calcitonin 1980. Chemistry, Physiology, Pharmacology, and Clinical Aspects”, A. Pecile ed., Excerpta Medica, Amsterdam, pp. 277–287 (1981).Google Scholar
  49. 49.
    M. Yamamoto, S. Kumagai, S. Tachikawa, and M. Maeno, Lack of effect of levallorphan on analgesia induced by intracerebroventricular application of porcine calcitonin in mice, Europ. J. Pharmacol. 55:211–213 (1979).CrossRefGoogle Scholar
  50. 50.
    P. C. Braga, S. Ferri, A. Santagostino, V. R. Olgiati, A. Pecile, Lack of opiate receptor involvement in centrally induced calcito-nin analgesia, Life Sci.22: 971–978 (1978).Google Scholar
  51. 51.
    H. Henke, F. A. Tschopp, J. A. Fischer, Distinct binding sites for calcitonin gene-related peptide and salmon calcitonin in rat central nervous system, Brain Res.360: 165–171 (1985).Google Scholar
  52. 52.
    Nakamuta, S. Furukawa, M. Koida, H Yajima, R. C. Orlowski, R. Schlueter, Specific binding of 125I-salmon calcitonin to rat brain: regional variation and calcitonin specificity, Japan J, Pharmacol. 31:53–60 (19817.Google Scholar
  53. 53.
    C. Gennari, S. M. Chierichetti, M. Piolini, C. Vibelli, D. Agnusdei, R. Civitelli, and S. Gonnelli, Analgesic activity of salmon and human calcitonin against cancer pain: a double-blind, placebo-controlled clinical study, Curr. Ther. Res. 38:298–308 (1985).Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Carlo Gennari
    • 1
  1. 1.Institute of Medical SemeioticsUniversity of SienaSienaItaly

Personalised recommendations